|
|||||
|
|
||||||
© 2001 American Society for Clinical Oncology
Unusual Presentations of Thoracic TumorsCase 2. Malignant Mesothelioma Mimicking Rheumatoid PleurisyTokyo Womens Medical University, National Murayama Hospital, National Tokyo Hospital, and National Defense Medical College, Japan In December 1999, a 59-year-old man, a smoker, was referred to the rheumatology service by his primary care physician. The patient exhibited right shoulder arthralgia with morning stiffness of the shoulder joint in September; analgesics brought only limited relief. In addition, he suffered from dyspnea, chest pain, and low-grade fevers, along with right-sided, massive pleural effusions. He had no digital clubbing. Rheumatoid pleurisy was suspected, as were metastatic lung cancer and pulmonary tuberculosis. Results of blood studies were as follows: erythrocyte sedimentation rate, 59 mm/h; WBC count, 9,660/mL; hemoglobin level, 14.4 g/dL; platelet count, 46.0 x 104/mL; serum protein level, 6.9 g/dL; lactate dehydrogenase level, 311 U/L; C-reactive protein level, 7.1 mg/dL; rheumatoid factor, positive; antinuclear antibody, positive (1:160); carcinoembryonic antigen level, 1.5 ng/mL; and hyaluronic acid level, 150 ng/mL (reference range, < 50 ng/mL). The pleural effusion showed the following: TP, 4.4 g/dL; lactate dehydrogenase level, 433 U/L; adenosine deaminase level, 20.4 IU/L; carcinoembryonic antigen level, 0.8 ng/mL; hyaluronic acid level, not measured; culture of tubercle bacillus and other bacteria, negative; and cytodiagnosis, class IIIa. After the effusion was drained, chest x-ray (Fig 1) and computed tomography scan (Fig 2) revealed many masses in the pleura covering the underlying normal lung. A diffuse mesothelioma or a metastatic pleural tumor was suspected, since rheumatoid pleurisy had been ruled out. Hematoxylin and eosin stain of the pleural biopsy specimen showed neoplastic cells and the presence of hyaluronic acid but no asbestos bodies (Fig 3). Mesothelioma markers, such as calretinin (Fig 4) and cytokeratin 5/6, were positively stained.1 The patient was diagnosed as having malignant mesothelioma (epithelioid type). Approximately two thirds of mesotheliomas are associated with asbestos exposure,2 and the occasional appearance of nonorgan-specific autoantibodies, such as antinuclear antibodies and rheumatoid factor, has been associated with asbestos exposure.3 However, our patient had no definite history of such exposure.
Although this case is a typical malignant mesothelioma, we initially suspected rheumatoid pleurisy, which is more common in middle-aged men than in typical female patients with rheumatoid arthritis. Arthralgia was the initial symptom in 3.2% of the patients with pleural mesothelioma in China,4 and a similar case of a patient who first complained of shoulder pain with mesothelioma has been reported.5 Moreover, high pleural fluid hyaluronan occurs not only in malignant mesothelioma but also in certain nonmalignant inflammatory diseases, especially rheumatoid arthritis.6 Both rheumatoid arthritis and mesothelioma may also reveal increases in serum hyaluronan.7 Pleural thickening in a 64-year-old man with rheumatoid arthritis and exposure to asbestos has also been described; however, the case was finally confirmed to be rheumatoid pleurisy with pulmonary asbestosis.8 Although mesotheliomas are much less frequent than metastatic pleural involvement and rheumatoid pleurisy, this case re-emphasizes that they can also be an etiologic factor of pleural effusions and that aggressive pleural biopsy is useful in confirming the diagnosis. REFERENCES 1. Cury PM, Butcher DN, Fisher C, ET AL: Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13: 107-112, 2000[Medline] 2. Boylan AM: Mesothelioma: new concepts in diagnosis and management. Curr Opin Pulm Med 6: 157-163, 2000[Medline] 3. Turner-Warwick M, Parkes WR: Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J 3: 492-495, 1970 4. An analysis of 310 cases of pleural mesothelioma. Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 13:216-220, 254-255, 1990 (in Chinese, English abstract) 5. Mazel JA, Roolvink EG: Clinical judgment and decision making in medical practice: A patient with shoulder symptoms. Ned Tijdschr Geneeskd 141: 2234-2238, 1997 (in Dutch, English abstract)[Medline] 6. Soderblom T, Pettersson T, Nyberg P, et al: High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J 13: 519-522, 1999[Abstract] 7. Laurent TC, Laurent UB, Fraser JR: Serum hyaluronan as a disease marker. Ann Med 28: 241-253, 1996[Medline] 8. Case records of the Massachusetts General Hospital: Weekly clinicopathological exercisesCase 27-1982. Pleural thickening in a man with rheumatoid arthritis and exposure to asbestos. N Engl J Med 307: 104-112, 1982[Medline]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|